Lobe Sciences Ltd.
LOBE
CNSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.22% | 1.60% | -74.18% | -62.78% | -40.65% |
| Total Depreciation and Amortization | -- | -- | -100.00% | -71.64% | -20.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.75% | -66.94% | 1,366.49% | 586.03% | 564.51% |
| Change in Net Operating Assets | 124.09% | 59.24% | -20.21% | -58.26% | -39.51% |
| Cash from Operations | -180.32% | -198.82% | 8.04% | -290.80% | 22.56% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -70.04% | -70.04% | 2,484.64% | 1,010.00% | 67.21% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 2,120.54% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,416.99% | 1,408.31% | 2,391.42% | 1,339.19% | 53.31% |
| Foreign Exchange rate Adjustments | -346.28% | -878.57% | -475.00% | -151.43% | 944.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27,956.95% | 5,500.00% | 1,140.52% | 111.33% | 95.06% |